Details for New Drug Application (NDA): 083383
✉ Email this page to a colleague
NDA 083383 describes DIUCARDIN, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the DIUCARDIN profile page.
The generic ingredient in DIUCARDIN is hydroflumethiazide. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide profile page.
The generic ingredient in DIUCARDIN is hydroflumethiazide. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide profile page.
Summary for 083383
| Tradename: | DIUCARDIN |
| Applicant: | Wyeth Ayerst |
| Ingredient: | hydroflumethiazide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083383
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
